Luke H. Hoeppner

1.7k total citations
44 papers, 1.1k citations indexed

About

Luke H. Hoeppner is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Luke H. Hoeppner has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Luke H. Hoeppner's work include Angiogenesis and VEGF in Cancer (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Prostate Cancer Treatment and Research (6 papers). Luke H. Hoeppner is often cited by papers focused on Angiogenesis and VEGF in Cancer (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Prostate Cancer Treatment and Research (6 papers). Luke H. Hoeppner collaborates with scholars based in United States, Germany and China. Luke H. Hoeppner's co-authors include Jennifer J. Westendorf, Frank J. Secreto, Sk. Kayum Alam, Debabrata Mukhopadhyay, Li Wang, Matteo Astone, Rendong Yang, Enfeng Wang, Ying Wang and Anja C. Roden and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular Cell.

In The Last Decade

Luke H. Hoeppner

41 papers receiving 1.1k citations

Peers

Countries citing papers authored by Luke H. Hoeppner

Since Specialization

Citations

This map shows the geographic impact of Luke H. Hoeppner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke H. Hoeppner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke H. Hoeppner more than expected).

Fields of papers citing papers by Luke H. Hoeppner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke H. Hoeppner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke H. Hoeppner. The network helps show where Luke H. Hoeppner may publish in the future.

Co-authorship network of co-authors of Luke H. Hoeppner

This figure shows the co-authorship network connecting the top 25 collaborators of Luke H. Hoeppner. A scholar is included among the top collaborators of Luke H. Hoeppner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke H. Hoeppner. Luke H. Hoeppner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal Neuropathological Consequences of Extracranial Radiation Therapy in Mice 2024 ·International Journal of Molecular Sciences ·Kimberly Demos-Davies, Jessica Lawrence, (unknown), (unknown), (unknown), Luke H. Hoeppner, Davis Seelig	1
2	Radiation dermatitis in the hairless mouse model mimics human radiation dermatitis 2024 ·Scientific Reports ·Jessica Lawrence, Davis Seelig, Kimberly Demos-Davies, (unknown), Yanan Ren, Li Wang, Sk. Kayum Alam, Rendong Yang, Alonso Guedes, (unknown), Luke H. Hoeppner	0
3	The crosstalk between neuropilin-1 and tumor necrosis factor-α in endothelial cells 2024 ·Frontiers in Cell and Developmental Biology ·Ying Wang, Enfeng Wang, (unknown), (unknown), (unknown), Shamit K. Dutta, Baoan Ji, Luke H. Hoeppner, Sreenivasulu Kilari, Sanjay Misra, Thomas R. Caulfield, Craig W. Vander Kooi, Harald Wajant, (unknown)	2
4	IKKα promotes lung adenocarcinoma growth through ERK signaling activation via DARPP-32-mediated inhibition of PP1 activity 2023 ·npj Precision Oncology ·Sk. Kayum Alam, Li Wang, Zhu Zhu, Luke H. Hoeppner	4
5	Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target 2023 ·Oncogene ·Marina G. Ferrari, (unknown), Li Wang, Luke H. Hoeppner, Paari Murugan, Eunsil Hahm, Jindan Yu, Timothy M. Kuzel, Sergio A. Gradilone, (unknown)	4
6	PLCβ2 Promotes VEGF-Induced Vascular Permeability 2022 ·Arteriosclerosis Thrombosis and Vascular Biology ·Kathryn N. Phoenix, Zhichao Yue, Lixia Yue, Chunxia Cronin, Bruce T. Liang, Luke H. Hoeppner, Kevin P. Claffey	16
7	Assessing Molecular Regulation of Vascular Permeability Using a VEGF-Inducible Zebrafish Model 2022 ·Methods in molecular biology ·Luke H. Hoeppner	1
8	Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability 2021 ·Disease Models & Mechanisms ·Li Wang, Matteo Astone, Sk. Kayum Alam, Zhu Zhu, Wuhong Pei, David A. Frank, Shawn M. Burgess, Luke H. Hoeppner	52
9	Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury 2021 ·Mayo Clinic Proceedings ·Stella Hartono, Victoria M. Bedell, Sk. Kayum Alam, (unknown), (unknown), (unknown), Krishnendu Pal, Rachel A. Kudgus, Priyabrata Mukherjee, Davis Seelig, Alexander Meves, Debabrata Mukhopadhyay, Stephen C. Ekker, Luke H. Hoeppner	14
10	Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1 2021 ·iScience ·Ying Wang, Ramcharan Singh Angom, Tanmay Kulkarni, Luke H. Hoeppner, Krishnendu Pal, Enfeng Wang, (unknown), (unknown), Shamit K. Dutta, Baoan Ji, Natalia Jarzebska, Yingjie Chen, Roman N. Rodionov, Debabrata Mukhopadhyay	2
11	Meta-Research: Creating clear and informative image-based figures for scientific publications 2020 ·OSF Preprints (OSF Preprints) ·(unknown), (unknown), (unknown), Iuliia Ferling, Steven Burgess, Vivek Bhardwaj, (unknown), (unknown), (unknown), Tracy Audisio, (unknown), (unknown), Małgorzata Anna Gazda, Helena Jambor, Luke H. Hoeppner, (unknown), Alberto Antonietti, Bradly Alicea, (unknown)	2
12	Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β 2019 ·Journal of Biological Chemistry ·Ying Wang, Luke H. Hoeppner, Ramcharan Singh Angom, Enfeng Wang, Shamit K. Dutta, (unknown), (unknown), Tao Shen, Isobel A. Scarisbrick, Sushovan Guha, Peter Störz, Resham Bhattacharya, Debabrata Mukhopadhyay	9
13	BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models 2018 ·Clinical Cancer Research ·(unknown), (unknown), Matteo Astone, Marina G. Ferrari, (unknown), (unknown), Aijaz Parray, Hifzur R. Siddique, Tabish Hussain, Paari Murugan, Colm Morrissey, Shahriar Koochekpour, Yibin Deng, Badrinath R. Konety, Luke H. Hoeppner, Mohammad Saleem	22
14	Fishing for cures: The alLURE of using zebrafish to develop precision oncology therapies 2017 ·npj Precision Oncology ·Matteo Astone, (unknown), Sk. Kayum Alam, Luke H. Hoeppner	41
15	RhoC maintains vascular homeostasis by regulating VEGF-induced signaling in endothelial cells 2015 ·Development ·Luke H. Hoeppner, Sutapa Sinha, Ying Wang, Resham Bhattacharya, Shamit K. Dutta, Xun Gong, Victoria M. Bedell, (unknown), (unknown), Ramani Ramchandran, Stephen C. Ekker, Debabrata Mukhopadhyay	8
16	Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells 2014 ·Molecular Oncology ·Luke H. Hoeppner, Ying Wang, Anil Kumar Sharma, Naureen Javeed, Virginia P. Van Keulen, Enfeng Wang, Ping Yang, Anja C. Roden, Tobias Peikert, Julian R. Molina, Debabrata Mukhopadhyay	73
17	Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial α5 Integrin 2013 ·Cancer Research ·Ying Cao, Luke H. Hoeppner, (unknown), (unknown), Yan Guo, Enfeng Wang, Jianmin Wu, Mark J. Cowley, David K. Chang, Nicola Waddell, Sean M. Grimmond, Andrew V. Biankin, Roger J. Daly, Xiao Hui Zhang, Debabrata Mukhopadhyay	86
18	Lef1ΔN Binds β-Catenin and Increases Osteoblast Activity and Trabecular Bone Mass 2011 ·Journal of Biological Chemistry ·Luke H. Hoeppner, Frank J. Secreto, (unknown), (unknown), Jennifer J. Westendorf	24
19	Wnt signaling as a therapeutic target for bone diseases 2009 ·Expert Opinion on Therapeutic Targets ·Luke H. Hoeppner, Frank J. Secreto, Jennifer J. Westendorf	192
20	Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation 2008 ·Matrix Biology ·Rachel A. Kahler, (unknown), Luke H. Hoeppner, Eric Jensen, (unknown), Julia Thom Oxford, Jennifer J. Westendorf	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact